Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinomaVladimir Bilim, Yoshihiko Tomita|British Journal of Cancer|2009Cited by 107
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancerHiroo Kuroki, Yoshihiko Tomita|Scientific Reports|2019Cited by 60
Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosisVladimir Bilim, Yoshihiko Tomita|British Journal of Cancer|2008Cited by 49
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer CellsYuko Shirono, Yoshihiko Tomita|Current Oncology|2023Cited by 3
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell CarcinomaMasaki Murata, Yoshihiko Tomita|Current Issues in Molecular Biology|2023Cited by 2